23 results
8-K/A
CMMB
Chemomab Therapeutics Ltd
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am
affairs and sales and marketing. Chemomab may have difficulty identifying, hiring and integrating new personnel. Future growth would impose significant
424B3
y8o9b1o1a706dzedbd
12 Feb 21
Prospectus supplement
12:05pm
S-4/A
i3obxrskxnclaao5mgn
10 Feb 21
Registration of securities issued in business combination transactions (amended)
1:19pm
S-4
1z1qx k4m
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
DEF 14A
4axixc1w
6 Apr 20
Definitive proxy
6:11am
PRE 14A
ph1a99vmd0mvbgpz36v9
30 Mar 20
Preliminary proxy
5:03pm
10-K
kj9ejo
17 Mar 20
Annual report
5:27pm
20-F/A
3h2 ufsla1pwnq
24 Apr 19
Annual report (foreign) (amended)
5:19pm
424B4
imrcfx3kf9v
13 Feb 19
Prospectus supplement with pricing info
8:20am
F-1/A
ureaboxcv
11 Feb 19
Registration statement (foreign) (amended)
9:52am
F-1/A
yjpqssine7
8 Feb 19
Registration statement (foreign) (amended)
12:00am
F-1/A
of5kbl8bbrh5fxpv
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1
qldzj8fw6p cx4o
7 Jan 19
Registration statement (foreign)
5:11pm
F-1
EX-10.7
0otuk8cawmemg
7 Jan 19
Registration statement (foreign)
5:11pm